We and others (13–16) have previously shown that deletion of GH signaling in liver creates an insulin resistant state with compensatory hyperinsulinemia, disturbed glucose tolerance, and clinical hepatic steatosis from increased TG synthesis and decreased hepatic TG export. This evidence concerns the gene GH1 and Hyperinsulinemia.